Plasma fluorescein and fluorescein glucuronide in patients with selected eye diseases

Systemically administered fluorescein (F) is rapidly transformed to the fluorescent metabolite fluorescein glucuronide (FG). Little is known about how diseases can influence the synthesis or disposition of FG. We studied F and FG in the plasma ultrafiltrate of 75 people who were normal or had diabet...

Full description

Saved in:
Bibliographic Details
Published in:Graefe's archive for clinical and experimental ophthalmology 1989-01, Vol.227 (2), p.114-117
Main Authors: BLAIR, N. P, EVANS, M. A, LESAR, T. S, WILLETT, M
Format: Article
Language:English
Subjects:
Adult
Aqueous Humor - physiology
Biological and medical sciences
Diabetes Mellitus - blood
Eye Diseases - blood
Eye Diseases - physiopathology
Female
Fluorescein
Fluoresceins - blood
Fluorometry
Humans
Male
Medical sciences
Ophthalmology
Retinal Detachment - blood
Retinitis Pigmentosa - blood
Ultrafiltration
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Systemically administered fluorescein (F) is rapidly transformed to the fluorescent metabolite fluorescein glucuronide (FG). Little is known about how diseases can influence the synthesis or disposition of FG. We studied F and FG in the plasma ultrafiltrate of 75 people who were normal or had diabetes, retinitis pigmentosa, or idiopathic rhegmatogenous retinal detachment. F and FG were determined by high-performance liquid chromatography. The concentration of FG was comparable to F 1 h after an intravenous injection of F, both in normal subjects and in patients with retinitis pigmentosa, which suggests that FG may not be an important contributor to the vitreous fluorescence at that time. At later times FG substantially exceeded F. The concentration of FG was significantly higher in diabetics than in the other groups 14 h after an oral dose of F. Accordingly, the possible effect of disease on plasma dye concentrations should be considered in studies measuring F by fluorescence hours after systemic F administration, since this could influence the intraocular fluorescence irrespective of any alteration in ocular function.
ISSN:0721-832X
1435-702X
DOI:10.1007/BF02169781